Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast
- 1 January 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 86 (1) , 44-50
- https://doi.org/10.1016/s1081-1206(10)62354-x
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- FexofenadineDrugs, 2000
- Clinical Pharmacology of New Histamiine H1 Receptor AntagonistsClinical Pharmacokinetics, 1999
- Patterns of inflammatory responses following rechallenge of skin late-phase allergic reaction sitesJournal of Allergy and Clinical Immunology, 1998
- Peripheral H1-Blockade Effect of FexofenadineAnnals of Allergy, Asthma & Immunology, 1997
- Cellular inflammatory responses and mediator release during early developing late-phase allergic cutaneous inflammatory responses: Effects of cetirizineJournal of Allergy and Clinical Immunology, 1997
- Effect of cetirizine and prednisolone on cellular infiltration and cytokine mRNA expression during allergen‐induced late cutaneous responsesClinical and Experimental Allergy, 1996
- The effect of a single oral dose of prednisolone or cetirizine on inflammatory cells infiltrating allergen‐induced cutaneous late‐phase reactions in atopic subjectsClinical and Experimental Allergy, 1992
- Effect of H1-receptor blockade on late cutaneous reactions to antigen: A double-blind, controlled studyJournal of Allergy and Clinical Immunology, 1991
- Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reactionJournal of Allergy and Clinical Immunology, 1989
- Allergen‐induced hyperreactivity is not a feature of dermal immediate allergic reactions—in contrast to reactions of airways mucosaClinical and Experimental Allergy, 1988